Figure 8Figure 8
Incidence of vancomycin-resistant enterococci (VRE) infection and implemented infection control measures in ward A. ( a ) Consumption of hand disinfectants and disinfecting wipes. *Data before September 2017 were not available. ( b ) Local prevalence of VRE colonization and days of therapy (DOT) with vancomycin. ASP antimicrobial stewardship program, ID infectious disease. ( c ) Correlation between the incidence of VRE infection and local prevalence of VRE colonization. ( d ) Correlation between local prevalence of VRE colonization and DOT with vancomycin.